Indapamid-Hemihydrat Heumann (Indapamide Hemihydrate)

Indapamide acts on the renal distal convoluted tubule to promote diuresis, making it useful in several cardiovascular‑related conditions.

• Hypertension: lowers systolic and diastolic blood pressure by reducing plasma volume and peripheral resistance.
• Edema: decreases excess interstitial fluid associated with heart, liver or kidney disease.
• Heart failure: assists in controlling fluid overload and improves symptom management.

• Indapamide hemihydrate inhibits the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule, reducing sodium and chloride reabsorption. This leads to increased urinary excretion of water and electrolytes, lowering plasma volume and peripheral vascular resistance, which together contribute to blood pressure reduction and edema resolution.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Increased urination: more frequent need to void due to diuretic action.
• Electrolyte imbalance: low potassium or sodium levels may occur.
• Headache: mild to moderate pain in the head region.
• Nausea: feeling of stomach discomfort or urge to vomit.

Serious or Rare Side Effects

• Severe dehydration: excessive fluid loss leading to hypotension.
• Acute electrolyte disturbances: marked hypokalemia or hyponatremia requiring medical attention.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.
• Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

• Monitor electrolytes: check serum potassium and sodium regularly.
• Assess renal function: evaluate creatinine clearance before and during treatment.
• Use caution in gout: diuretic‑induced hyperuricemia may precipitate attacks.
• Adjust in hepatic impairment: consider dose reduction in severe liver disease.
• Elderly patients: start at lower dose and monitor for orthostatic hypotension.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid)

• Lithium: increased lithium levels may cause toxicity.
• Cyclosporine: combined use can exacerbate nephrotoxicity.
• High‑dose NSAIDs: may reduce diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: risk of additive blood pressure lowering and hyperkalemia.
• Beta‑blockers: may enhance antihypertensive effect, requiring dose adjustment.
• Digoxin: altered serum levels may occur, necessitating monitoring.
• Corticosteroids: may increase risk of electrolyte disturbances.